ARNA Related Guidance
-
UPDATE: Arena Pharmaceuticals (ARNA) Narrows Q4 GAAP Loss to 10c/Share
-
Arena Pharmaceuticals (ARNA) Tops Q3 EPS by 7c, Updates Guidance
-
Arena Pharmaceutical (ARNA) Reports Q3 Loss, Lowers 2006 Revenue Outlook
Back to ARNA Stock Lookup
